Angiogenesis and the fibrinolytic system

Seminars in Thrombosis and Hemostasis

Volumn 22, Issue 6, 1996, Pages 517-524

  Pintucci, Giuseppe ^a,d   Bikfalvi, Andreas ^a,c   Klein, Sharon ^a,b   Rifkin, Daniel B ^a,b  

^a Kaplan Cancer Center   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiogenesis; endothelial cells; growth factors; plasminogen activators; proteases

Indexed keywords

PLASMINOGEN ACTIVATOR; PROTEINASE;

ANGIOGENESIS; ENDOTHELIUM CELL; FIBRINOLYSIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030468821     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-999054     Document Type: Review

References (124)

1. Folkman J, Y Shing: Angiogenesis. J Biol Chem 267:10931-10934, 1992.
2. Moscatelli D, E Jaffe, DB Rifkin: Tetradecanoyl phorbol acetate stimulates latent collagenase production by cultured human endothelial cells. Cell 20: 343-351, 1980.
3. Gross JL, D Moscatelli, DB Rifkin: Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro. Proc Natl Acad Sci USA 80:2623-2627, 1983.
4. Basilico C, D Moscatelli: The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115-165, 1992.
5. Burgess WH, T Maciag: The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58:575-606, 1989.
6. Stewart R, J Nelson, DJ Wilson: Epidermal growth factor promotes chick embryonic angiogenesis. Cell Biol Int Rep 13:957-965, 1989.
7. Pepper MS, N Ferrara, L Orci, R Montesano: Vascular endothelial cell growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902-906, 1991.
8. Ferrara N, H Heinsohn, CE Walder, S Bunting, GR Thomas: The regulation of blood vessel growth by vascular endothelial growth factor. Ann NY Acad Sci 752:246-256, 1995.
9. Grant DS, HK Kleinman, ID Goldberg, MM Bhargava, BJ Nickoloff, JL Kinsella, P Polverini, EM Rosen: Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90:1937-1941, 1993.
10. Schreiber AB, ME Winkler, R Derynck: Transforming growth factor-alpha: A more potent angiogenic mediator than epidermal growth factor. Science 232:1250-1253, 1986.
11. Roberts AB, MB Sporn, RK Assoian, JM Smith, NS Roche, LM Wakefield, UI Heine, LA Liotta, V Falanga, JH Kehrl, AS Fauci: Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171, 1986.
12. Yang EY, HL Moses: Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chick chorioallantoic membrane. J Cell Biol 111:731-741, 1990.
13. Vassalli JD, AP Sappino, D Belin: The plasminogen activator/plasmin system. J Clin Invest 88:1067-1072, 1991.
14. Werb Z, MJ Banda, PA Jones: Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins and collagen by proteinases isolated from macrophages. J Exp Med 152:1340-1357, 1980.
15. Mignatti P, DB Rifkin: Biology and biochemistry of proteinases in tumour invasion. Physiol Rev 73:161-195, 1993.
16. Mignatti P: Extracellular matrix remodeling by metalloproteinases and plasminogen activators. Kidney Int 47:S-12-S-14, 1995.
17. Sprengers ED, C Kluft: Plasminogen activator inhibitors. Blood 69:381-387, 1987.
18. Loskutoff DJ, TS Edgington: Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci USA 74: 3903-3907, 1977.
19. Plow EF, J Felez, LA Miles: Cellular regulation of fibrinolysis. Thromb Haemostas 66:32-36, 1991.
20. Vassalli JD, D Baccino, D Belin: A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol 100:86-92, 1985.
21. Stoppelli MP, A Corti, A Soffientini, G Cassani, F Blasi, RK Assoian: Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci USA 82:4939-4943, 1985.
22. 2-terminal amino acid sequence and glycosylation variants. J Biol Chem 265: 6453-6460, 1990.
23. Ploug M, E Rønne, N Behrendt, AL Jensen, F Blasi, K Danø: Cellular receptor for urokinase-type plasminogen activator. Carboxyl terminal processing and membrane anchoring by glycosyl-phosphatidyl inositol. J Biol Chem 266:1926-1933, 1991.
24. Ellis V, MF Scully, VV Kakkar: Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem 264:2185-2188, 1989.
25. Plow EF, T Herren, A Redlitz, LA Miles, JL Hoover-Plow: The cell biology of the plasminogen system. FASEB J 9:939-945, 1995.
26. Cubellis MV, TC Wun, F Blasi: Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J 9:1079-1085, 1990.
27. Estreicher A, J Muhlhauser, JL Carpentier, L Orci, JD Vassalli: The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol 111:783-792, 1990.
28. Olson D, J Pollanen, G Høyer-Hansen, E Rønne, K Sakaguchi, TC Wun, E Appella, K Danø, F Blasi: Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. J Biol Chem 267:9129-9133, 1992.
29. Axelrod JH, R Reich, R Miskin: Expression of the human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells. Mol Cell Biol 9:2133-2141, 1989.
30. Del Rosso M, G Fibbi, G Dini, C Grappone, M Pucci, R Caldini, L Magnelli, M Fimiani, T Lotti, E Panconesi: Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes. J Invest Dermatol 94:310-316, 1990.
31. Odekon LE, Y Sato, DB Rifkin: Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol 150:258-263, 1992.
32. Busso N, SK Masur, D Lazega, S Waxman, L Ossowski: Induction of cell migration by pro-urokinase binding to its receptor: Possible mechanism for signal transduction in human epithelial cells. J Cell Biol 126:259-270, 1994.
33. Ossowski L, G Clunie, MT Masucci, F Blasi: In vivo paracrine interaction between urokinase and its receptor: Effect on tumor cell invasion. J Cell Biol 115:1107-1112, 1991.
34. Kook YH, J Adamski, A Zelent, L Ossowski: The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy. EMBO J 13:3983-3991, 1994.
35. Hajjar KA, NM Hamel: Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. J Biol Chem 265:2908-2916, 1990.
36. Felez J, CJ Chanquia, P Fabregas, EF Plow, LA Miles: Competition between plasminogen and tissue plasminogen activator for cellular binding sites. Blood 82:2433-2441, 1993.
37. Hajjar KA, AT Jacovina, J Chacko: An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 269:21191-21197, 1994.
38. Shin GC, KA Hajjar: Plasminogen and plasminogen activator assembly on the human endothelial cell. Proc Soc Exp Biol Med 202:258-264, 1993.
39. Dvorak HF, LF Brown, M Detmar, AM Dvorak, Vascular permeability factor/vascular endothelial growth factor, microvascular permeability, and angiogenesis. Am J Pathol 146:1029-1039, 1995.
40. Connolly DT, DM Heuvelman, R Nelson, JV Olander, BL Eppley, JJ Delfino, NR Siegel, RM Leimgruber, J Feder: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478, 1989.
41. Leung DW, G Cachianes, WJ Kuang, DV Goeddel, N Ferrara: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309, 1989.
42. 165 and PDGF-BB. Anat Embryol 186:251-257, 1992.
43. Shweiki D, A Itin, D Soffer, E Keshet: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845, 1992.
44. Goldberg MA, TJ Schneider: Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269:4355-4359, 1994.
45. Levy AP, NS Levy, S Wegner, MA Goldberg: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270:13333-13340, 1995.
46. Mason IJ: The ins and outs of fibroblast growth factors. Cell 78:547-552, 1994.
47. Florkiewicz RZ, A Sommer: Human basic fibroblast growth factor gene encodes four polypeptides: Three initiate translation from non-AUG codons. Proc Natl Acad Sci USA 86:3978-3981, 1989.
48. Prats H, M Kaghad, AC Prats, M Klagsbrun, JM Lelias, P Liauzun, P Chalon, JP Tauber, F Amalric, JA Smith, D Caput: High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc Natl Acad Sci USA 86: 1836-1840, 1989.
49. Moscatelli D, J Joseph-Silverstein, R Manejias, DB Rifkin: Mr 25,000 heparin-binding protein from guinea pig brain is a high molecular weight form of basic fibroblast growth factor. Proc Natl Acad Sci USA 84:5778-5782, 1987.
50. Patry V, E Arnaud, F Amalric, H Prats: Involvement of basic fibroblast growth factor NH2 terminus in nuclear accumulation. Growth Factors 11:163-174, 1994.
51. Renko M, N Quarto, T Morimoto, DB Rifkin: Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol 144:108-114, 1990.
52. Florkiewicz RZ, A Baird, AM Gonzalez: Multiple forms of bFGF: Differential nuclear and cell surface localization. Growth Factors 4:265-275, 1991.
53. Abraham JA, A Mergia, JL Whang, A Tumolo, J Friedman, KA Hjerrild, D Gospodarowicz, JC Fiddes: Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233:545-548, 1986.
54. Mignatti P, T Morimoto, DB Rifkin: Basic fibroblast factor released by single isolated cells stimulates their migration in an autocrine manner. Proc Natl Acad Sci USA 88:11007-11011, 1991.
55. Mignatti P, T Morimoto, DB Rifkin: Basic fibroblast factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 151:81-93, 1992.
56. Bikfalvi A, S Klein, G Pintucci, N Quarto, P Mignatti, DB Rifkin: Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: Possible intracellular signaling by the high molecular weight forms. J Cell Biol 129:233-243, 1995.
57. Florkiewicz RZ, RA Majack, RD Buechler, E Florkiewicz: Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway. J Cell Physiol 162: 388-399, 1995.
58. Moscatelli D: High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol 131: 123-130, 1987.
59. Jaye M, J Schlessinger, CA Dionne: Fibroblast growth factor receptor tyrosine kinases: Molecular analysis and signal transduction. Biochim Biophys Acta 1135:185-199, 1997.
60. Fantl WJ, DE Johnson, LT Williams: Signalling by receptor tyrosine kinases. Annu Rev Biochem 62:453-481, 1993.
61. Logan A: Intracrine regulation at the nucleus - A further mechanism of growth factor activity? J Endocrinol 125:339-343, 1990.
62. Wiedlocha A, PO Falnes, IH Madshus, K Sandvig, S Olsnes: Dual mode of signal transduction by externally added acidic fibroblast growth factor. Cell 76:1039-1051, 1994.
63. Jans DA: Nuclear signaling pathways for polypeptide ligands and their membrane receptors? FASEB J 8:841-847, 1994.
64. Harpel JG, CN Metz, S Kojima, DB Rifkin: Control of transforming growth factor-β activity: Latency vs. activation. Prog Growth Factor Res 4:321-335, 1992.
65. Pircher R, P Jullien, DA Lawrence: β-Transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem Biophys Res Commun 136:30-37, 1986.
66. Miyazono K, U Hellman, C Westedt, CH Heldin: Latent high molecular weight complex of transforming growth factor β1. J Biol Chem 263:6407-6415, 1988.
67. Lyons RM, J Keski Oja, HL Moses: Proteolytic activation of latent transforming growth factor-β from fibroblast conditioned medium. J Cell Biol 106:1659-1665, 1988.
68. Lyons RM, LE Gentry, AF Purchio, HL Moses: Mechanism of activation of latent recombinant transforming growth factor β-1 by plasmin. J Cell Biol 110:1361-1367, 1990.
69. Sato Y, DB Rifkin: Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor β-1-like molecule by plasmin. J Cell Biol 109:309-315, 1989.
70. Sato Y, R Tsuboi, RM Lyons, HL Moses, DB Rifkin: Characterization of the activation of latent TGFβ by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self-regulating system. J Cell Biol 111:757-763, 1990.
71. Wakefield LM, DM Smith, T Masui, CC Harris, MB Sporn: Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 105:965-975, 1987.
72. Derynck R: TGF-beta-receptor-mediated signaling. Trends Biochem Sci 19:548-553, 1994.
73. Naldini L, L Tamagnone, E Vigna, M Sachs, G Hartmann, W Birchmeier, Y Daikuhara, H Tsubouchi, F Blasi, PM Comoglio: Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 11: 4825-4833, 1992.
74. Miyazawa K, T Shimomura, D Naka, N Kitamura: Proteolytic activation of hepatocyte growth factor in response to tissue injury. J Biol Chem 269:8966-8970, 1994.
75. Boros P, CM Miller: Hepatocyte growth factor: A multifunctional cytokine. Lancet 345:293-295, 1995.
76. Zarnegar R, GK Michalopoulos: The many faces of hepatocyte growth factor: From hepatopoiesis to hematopoiesis. J Cell Biol 129:1177-1180, 1995.
77. Nakamura T, T Nishizawa, M Hagiya, T Seki, M Shimonishi, A Sugimura, K Tashiro, S Shimizu: Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440-443, 1989.
78. Bottaro DP, JS Rubin, DL Faletto, AML Chan, TE Kmiecik, GF Vande Woude, SA Aaronson: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802-804, 1991.
79. Kristensen P, LI Larsson, LS Nielsen, J Grøndahl-Hansen, PA Andreasen, K Danø: Human endothelial cells contain one type of plasminogen activator. FEBS Lett 168:33-37, 1984.
80. Bykowska K, EG Levin, DC Rijken, DJ Loskutoff, D Collen: Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cells. Biochim Biophys Acta 703:113-115, 1982.
81. Levin EG, DJ Loskutoff: Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J Cell Biol 94:631-636, 1982.
82. Bacharach E, A Itin, E Keshet: In vivo patterns of expression of urokinase and its inhibitors PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci USA 89:10686-10690, 1992.
83. Nathan C, M Sporn: Cytokines in context. J Cell Biol 113:981-986, 1991.
84. Moscatelli D, M Presta, DB Rifkin: Purification of a factor from human placenta that stimulates capillary endothelial cell protease production. DNA synthesis, and migration. Proc Natl Acad Sci USA 83:2091-2095, 1986.
85. Presta M, D Moscatelli, J Joseph-Silverstein, DB Rifkin: Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol Cell Biol 6:4060-4066, 1986.
86. Rifkin DB, D Moscatelli: Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 109:1-6, 1989.
87. Saksela O, D Moscatelli, DB Rifkin: The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol 105:957-963, 1987.
88. Pepper MS, D Belin, R Montesano, L Orci, JD Vassalli: Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 111:743-755, 1990.
89. Mignatti P, R Mazzieri, DB Rifkin: Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J Cell Biol 113:1193-1201, 1991.
90. Montesano R, L Orci: Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42:469-477, 1985.
91. Montesano R, MS Pepper, JD Vassalli, L Orci: Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors. J Cell Physiol 132:509-516, 1987.
92. Tsuboi R, DB Rifkin: Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity. Int J Cancer 46:56-60, 1990.
93. Pepper MS, R Montesano: Proteolytic balance and capillary morphogenesis. Cell Differ Dev 32:319-327, 1990.
94. Flaumenhaft R, M Abe, P Mignatti, DB Rifkin: Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: Regulation of plasminogen activator activity. J Cell Biol 118:901-909, 1992.
95. Saksela O, DB Rifkin: Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol 110:767-776, 1990.
96. Flaumenhaft R, DB Rifkin: Extracellular matrix regulation of growth factor and protease activity. Curr Opin Cell Biol 3:817-823, 1991.
97. Mignatti P, R Tsuboi, E Robbins, DB Rifkin: In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol 108:671-682, 1989.
98. Pepper MS, AP Sappino, R Stocklin, R Montesano, L Orci, JD Vassalli: Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 122:673-684, 1993.
99. Bussolino F, MF Di Renzo, M Ziehe, E Bocchietto, M Olivero, L Naldini, G Gaudino, L Tamagnone, A Coffer, PM Comoglio: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119:629-641, 1992.
100. Pepper MS, K Matsumoto, T Nakamura, L Orci, R Montesano: Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol Chem 267:20493-20496, 1992.
101. Montesano R, K Matsumoto, T Nakamura, L Orci: Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67:901-908, 1991.
102. Wojta J, T Nakamura, A Fabry, P Hufnagl, R Beckmann, K McGrath, BR Binder: Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells. Blood 84:151-157, 1994.
103. Pepper MS, N Ferrara, L Orci, R Montesano: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824-831, 1992.
104. Mandriota SJ, G Seghezzi, JD Vassalli, N Ferrara, S Wasi, R Mazzieri, P Mignatti, MS Pepper: Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 270:9709-9716, 1995.
105. Houck KA, DW Leung, AM Rowland, J Winer, N Ferrara: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031-26037, 1992.
106. Schulze-Osthoff K, W Risau, E Vollmer, C Sorg: In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 137:85-92, 1990.
107. Peverali FA, S Mandriota, P Ciana, R Marelli, P Quax, DB Rifkin, G Della Valle, P Mignatti: Tumor cells secrete an angiogenic factor that stimulates baskc fibroblast growth factor and urokinase expression in vascular endothelial cells. J Cell Physiol 161:1-14, 1994.
108. Ferrara N: Vascular endothelial growth factor. The trigger for neovascularization in the eye. Lab Invest 72:615-618, 1995.
109. Koch AE, LA Harlow, GK Haines, EP Amento, EN Unemori, WL Wong, RM Pope, N Ferrara: Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149-4156, 1994.
110. Mussoni L, G Pintucci, G Romano, F De Benedetti, M Massa, A Martini: Decreased fibrinolytic activity in juvenile chronic arthritis. Ann Rheum Dis 49:973-975, 1990.
111. Weinberg JB, AM Pippen, CS Greenberg: Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheumatol 34: 996-1005, 1991.
112. Saxne T, I Lecander, P Geborek: Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis. J Rheumatol 20:91-96, 1993.
113. Koch AE, MM Halloran, CJ Haskell, MR Shah, PJ Polverini: Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376:517-519, 1995.
114. Pintucci G, L Iacoviello, MP Castelli, C Amore, V Evangelista, C Cerletti, MB Donati: Cathepsin G-induced release of PAI-1 in the culture medium of endothelial cells: A new thrombogenic role for polymorphonuclear leukocytes? J Lab Clin Med 122:69-79, 1993.
115. Totani L, A Piccoli, G Pallegrini, A Di Santo, R Lorenzet: Polymorphonuclear leukocytes enhance release of growth factors by cultured endothelial cells. Arterioscler Thromb 14:125-132, 1994.
116. Scully MF, W Li: Activation of single chain urokinase type plasminogen activator by calhepsin G. Abstracts of the Third International Workshop on "Molecular and Cellular Biology of Plasminogen Activation." Elsinore, Denmark, 1991, p 38.
117. McCarthy SA, I Kuzu, KC Gatter, R Bicknell: Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis. Trends Pharmacol Sci 12:462-467, 1991.
118. O'Reilly MS, L Holmgren, Y Shing, C Chen, RA Rosenthal, M Moses, WS Lane, Y Cao, EH Sage, J Folkman: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328, 1994.
119. Fidler IJ, LM Ellis: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185-188, 1994.
120. Enenstein J, NS Waleh, RH Kramer: Basic FGF and TGF-β differentially modulate integrin expression of human microvascular endothelial cells. Exp Cell Res 203:499-503, 1992.
121. Klein S, FG Giancotti, M Presta, SM Albelda, CA Buck, DB Rifkin: Basic fibroblast growth factor modulates integrin expression in microasculur endothelial cells. Mol Biol Cell 4:973-982, 1993.
122. Brooks PC, RA Clark, DA Cheresh: Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569-571, 1994.
123. Brooks PC, AM Montgomery, M Rosenfeld, RA Reisfeld, T Hu, G Klier, DA Cheresh: Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164, 1994.
124. v integrins. Science 270:1500-1502, 1995.